Replies to post #29004 on Humanigen Inc (fka HGENQ)

[jb128]

Damn you sound just like my friend at JPM! Your last several posts sound almost verbatim what he regurgitates from his butthurt employer.

[DonDonDonDon]

So promising GILD walked away.

Humanigen walked away. And it is promising. The trial showed that lenzilumab is effective with Gilead's Yescarta but now lenz will now be trialed in combination with every CAR-T treatment that is commercially available. If it is effective with multiple CAR-T therapies, which is likely since all of their toxicity issues stem from GM-CSF, the buyout price will be astronomical. Lenzilumab might literally make CAR-T viable.

[Scooter McCabe]

If you aren't following the news about the lack of vaccinations versus surplus of supply in the US, you are missing out on some vital market information.

The other arguments, well it's garbage.